ProfileGDS4890 / 240537_s_at
TitleSystemic lupus erythematosus patients and yellow fever vaccine-immunized healthy donors: CD16+ monocytes
OrganismHomo sapiens


SLE 1 SLE 2 SLE 3 SLE 4 ND 55 ND 56 ND 57 systemic lupus erythematosus healthy not immunized before YFV immunization after YFV immunization before YFV immunization after YFV immunization before YFV immunization after YFV immunization GSM1256968 GSM1256969 GSM1256970 GSM1256971 GSM1256988 GSM1256991 GSM1256989 GSM1256992 GSM1256990 GSM1256993 17% 19% 11% 21% 17% 5% 36% 20% 20% 21% sort by individual sort by disease state sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1256968SLE-patients; Group 3: CD16pos, resident monocytes; active SLE 11.9309917
GSM1256969SLE-patients; Group 3: CD16pos, resident monocytes; active SLE 22.2636619
GSM1256970SLE-patients; Group 3: CD16pos, resident monocytes; active SLE 31.2953611
GSM1256971SLE-patients; Group 3: CD16pos, resident monocytes; active SLE 42.9317721
GSM1256988Yellow fever vaccinated NDs; Group 8: CD16pos, resident monocytes; ND 55 before YFV2.0397217
GSM1256991Yellow fever vaccinated NDs; Group 9: CD16pos, resident monocytes; ND 55 seven days after YFV0.7839635
GSM1256989Yellow fever vaccinated NDs; Group 8: CD16pos, resident monocytes; ND 56 before YFV9.2284836
GSM1256992Yellow fever vaccinated NDs; Group 9: CD16pos, resident monocytes; ND 56 seven days after YFV2.5369720
GSM1256990Yellow fever vaccinated NDs; Group 8: CD16pos, resident monocytes; ND 57 before YFV3.0407520
GSM1256993Yellow fever vaccinated NDs; Group 9: CD16pos, resident monocytes; ND 57 seven days after YFV2.8108921